Optimizing Dacarbazine Therapy: Design of a Laser-Triggered Delivery System Based on β-Cyclodextrin and Plasmonic Gold Nanoparticles

Dacarbazine (DB) is an antineoplastic drug extensively used in cancer therapy. However, present limitations on its performance are related to its low solubility, instability, and non-specificity. To overcome these drawbacks, DB was included in β-cyclodextrin (βCD), which increased its aqueous solubi...

Descripción completa

Detalles Bibliográficos
Autores principales: Quintana-Contardo, Sebastián, Donoso-González, Orlando, Lang, Erika, Guerrero, Ariel R., Noyong, Michael, Simon, Ulrich, Kogan, Marcelo J., Yutronic, Nicolás, Sierpe, Rodrigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960602/
https://www.ncbi.nlm.nih.gov/pubmed/36839779
http://dx.doi.org/10.3390/pharmaceutics15020458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960602/
https://www.ncbi.nlm.nih.gov/pubmed/36839779
http://dx.doi.org/10.3390/pharmaceutics15020458

Ejemplares similares